首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷奈酸锶临床研究进展
引用本文:王林,闫勇,薛庆云.雷奈酸锶临床研究进展[J].中国药事,2013(8):850-854.
作者姓名:王林  闫勇  薛庆云
作者单位:[1]北京医院,北京100730 [2]山东肥城矿业集团中心医院,北京100730
摘    要:目的 对抗骨质疏松药物雷奈酸锶的整个研究过程进行分析,评价其各阶段研究的有效性.方法 简要总结雷奈酸锶各个阶段研究试验情况,系统概括近10年来雷奈酸锶的研究结论.结果 雷奈酸锶具有双重抗骨质疏松作用,能够有效地预防骨质疏松患者骨密度下降,显著降低骨质疏松骨折发生危险.结论 口服雷奈酸锶是治疗骨质疏松症的一种有效办法,应当成为抗骨质疏松治疗的一种新选择.

关 键 词:雷奈酸锶  骨质疏松症  药物治疗

Advance in Clinic Research for Strontium Ranelate
Wang Lin,Yan Yong,and Xue Qingyun.Advance in Clinic Research for Strontium Ranelate[J].Chinese Pharmaceutical Affairs,2013(8):850-854.
Authors:Wang Lin  Yan Yong  and Xue Qingyun
Institution:(Department of Orthopedics, Beijing Hospital, Beijing 100730; 1 Central Hospital of Shandong Feicheng Mining Group)
Abstract:Objective To summarize the study process of the anti-osteoporosis agent, strontium ranelate, and evaluate the effectiveness of strontium ranelate in each study stage. Methods Experimental status of strontium ranelate in each study stage was overviewed, and study conclusions of strontium ranelate published in recent ten years were summarized. Results Strontium ranelate has dual effects of bone formation induction and bone resorption reduction. This treatment with strontium ranelate could prevent the reduction of bone mineral density (BMD), and significantly decrease the risk of osteoporotie fracture. Conclusion Strontium ranelate is an efficient treatment of osteoporosis, and should be considered as a new choice.
Keywords:strontium ranelate  osteoporosis  drug therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号